Recently identified blood biomarkers for the diagnosis of concussion [8], such as matrix metalloproteinase 9 (MMP9) and galectin 3, whose synthesis is upregulated in response to injury, may represent potential targets for therapeutic intervention in mTBI. Here, MMP9 is linked to concussion.